AFP2 小时
Takeda Announces Approval of HYQVIA® 10% S.C. (Subcutaneous) Injection Set in Japan for ...
Takeda (TSE:4502/NYSE:TAK) today announced that the Japanese Ministry of Health, Labour and Welfare has approved the use of HYQVIA® [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluro ...
AD Magazine on MSN21 小时
Six Senses Kyoto, le nouvel hôtel à tester absolument au Japon
La capitale culturelle du Japon se dote d'un nouveau-né pointu dans le domaine de l'hôtellerie. Visite du Six Senses Kyoto, ...